Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [4072]

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and...

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia,

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia, )

Evaluation and definition of response and progression from trials to clinical...

Dr Andrew Armstrong - Duke University, Durham, North Carolina

Evaluation and definition of response and progression from trials to clinical practice ( Dr Andrew Armstrong - Duke University, Durham, North Carolina )

FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma

Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA

FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma ( Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA )

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle...

Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer ( Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA )

Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or...

Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA

$Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma ( Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA )$

The Vanessa Moss Prize: celebrating research into cancer health disparities

Dr Olubukola Ayodele - University Hospitals of Leicester NHS Trust, Leicester...

The Vanessa Moss Prize: celebrating research into cancer health disparities ( Dr Olubukola Ayodele - University Hospitals of Leicester NHS Trust, Leicester, UK )

Climate and environmental factors drive seasonal risk of invasive mucormycosis...

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA

Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )

Extreme heat exposure around diagnosis is linked to higher mortality in...

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA

Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )

Can public–private partnerships accelerate cancer research and clinical trials...

Prof Ahmed Hassan Abdel Aziz - Ain Shams University, Cairo, Egypt

Can public–private partnerships accelerate cancer research and clinical trials in LMICs? ( Prof Ahmed Hassan Abdel Aziz - Ain Shams University, Cairo, Egypt )

Global cancer burden, prevention, and inequalities across regions

Dr Raúl Murillo - San Ignacio University Hospital, Bogotá, Colombia

Global cancer burden, prevention, and inequalities across regions ( Dr Raúl Murillo - San Ignacio University Hospital, Bogotá, Colombia )

Reducing cancer burden through prevention

Dr Ernesto Gil Deza - Instituto Henry Moore, Buenos Aires, Argentina

Reducing cancer burden through prevention ( Dr Ernesto Gil Deza - Instituto Henry Moore, Buenos Aires, Argentina )

The tobacco industry's influence on science and healthcare professionals

Dr Sophie Braznell - University of Bath, Bath, UK

The tobacco industry's influence on science and healthcare professionals ( Dr Sophie Braznell - University of Bath, Bath, UK )

More from ecancer